Cargando…
Reducing Acneiform Rash Induced by EGFR Inhibitors With Honeysuckle Therapy: A Prospective, Randomized, Controlled Study
Background: Epidermal growth factor receptor inhibitors (EGFRIs), including cetuximab, erlotinib, gefitinib and icotinib, have been proven to be effective in treating colorectal cancer or lung cancer. However, most of patients who receive EGFRIs treatment experience cutaneous toxicities, such as acn...
Autores principales: | Liu, Zhen, Tian, Tian, Wang, Binbin, Lu, Demin, Ruan, Jian, Shan, Jianzhen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8894807/ https://www.ncbi.nlm.nih.gov/pubmed/35250582 http://dx.doi.org/10.3389/fphar.2022.835166 |
Ejemplares similares
-
Acneiform rash during lung cancer therapy with erlotinib (Tarceva(®))
por: Owczarczyk-Saczonek, Agnieszka, et al.
Publicado: (2013) -
Changes in sebum levels and the development of acneiform rash in patients with non–small cell lung cancer after treatment with EGFR inhibitors
por: Nakahara, Takeshi, et al.
Publicado: (2015) -
Panitumumab-Induced Acneiform Rash in a Patient with Metastatic Colon Adenocarcinoma
por: Martins-Filho, Paulo Ricardo Saquete, et al.
Publicado: (2013) -
Treatment of Acneiform Rash Due to Bromide of Potassium, While Continuing the Remedy
Publicado: (1882) -
The application of gargle containing honeysuckle and semen oroxyli to reduce the pain and complications after uvulopalatopharyngoplasty
por: Ren, Lihua, et al.
Publicado: (2022)